 |
市場調查報告書
商品編碼
1198561
天氣預報市場——增長、趨勢、COVID-19 的影響和預測 (2023-2028)Synoptophore Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
在預測期內，同視素市場預計將以 4% 左右的複合年增長率增長。
COVID-19 大流行導致醫療保健服務縮減了他們的眼保健活動，因為眼科檢查程序涉及與患者的密切互動，增加了感染風險。 美國眼科學會 (AAO) 建議眼科醫生暫停非緊急護理。 AAPOS 對 416 名會員進行的 2021 年會員調查發現，在 COVID-19 大流行期間，兒科眼科實踐受到了毀滅性的潛在影響。 兒童沒有在正確的時間得到正確的治療，阻礙了整個市場，因為非必要的眼科診所就診受到限制。
所研究市場的增長主要歸因於視力障礙發病率的增加、人們對視力障礙早期診斷意識的提高以及對非侵入性過程的需求不斷增長。
由於視覺障礙的增加，對同視眼的需求也在增加。 此外，隨著時間的推移，與視力障礙相關的中風和顱腦外傷等風險因素也在增加。 Synoptophor 的設備被認為對於糾正此類損傷非常可靠。 根據美國國家眼科研究所 (NEI) 2021 年的統計數據，大約 5% 至 16% 的人患有充血障礙 (CI) 障礙。 年輕人和成年人更容易出現視力障礙，從而促進了研究市場的增長。
人們對視力障礙早期診斷意識的提高預計將推動市場增長。 一些骨科協會鼓勵視力障礙的早期診斷，這推動了對視覺設備的需求。 根據國際正畸醫師協會（IOA）2021年的一篇文章，巴西正畸醫師協會將6月的第一個星期一定為“世界正畸日”。 根據國際防盲協會 (IAPB) 的說法，世界視覺日 (WSD) 是一年一度的宣傳日，旨在引起全球對失明和視力障礙的關注。 這些努力促進了視力障礙的早期診斷，增加了對 Synopsys 的需求。
然而，同視設備的高成本和用於治療視力障礙的替代藥物的可用性是阻礙市場增長的因素。
同視詞市場趨勢
預計在預測期內治療應用將大幅增長
根據應用，預計治療領域在預測期內將出現顯著增長。 同視機是主要用於治療眼球運動障礙的設備。 它提供了最全面的雙眼視力評估，並且非常可靠。 標準測量允許在存在視網膜對應異常和水平、垂直和扭轉眼部未對準的情況下評估融合幅度、同時感知和立體視覺。
2021 年 IEEE 會議表明，同視光眼越來越多地用於雙眼視覺 (BV)。 Synopphor 評估三個等級的 BV。 根據美國眼科學會 (AAO) 2020 年的統計數據，兒童各向異性弱視的患病率約為 5.2%。 弱視也是發達國家兒童和成人低視力的最常見原因，發病率為 3-6%。 遮蓋療法的成功率不是很高，通過使用刺激弱視眼的同視光眼可以大大提高視力。 因此，對聯視器的需求有助於治療醫療設施中的視力障礙。
由於上述原因，預計該行業在預測期內將顯著增長。
北美是同視鏡市場的主要區域
在北美，預計美國市場在預測期內將顯著增長。 該國市場增長的主要驅動力是斜視和弱視等視力障礙發病率的增加，以及對非手術治療程序的日益偏好。
根據 Prevent Blindness 2021 年的統計數據，在美國，永久性視力喪失的女性比男性多 3 人，比例為每 2 名男性對應 3 名女性。. 這推動了使用同視光眼矯正視力的採用。 此外，由於該地區的研究和開發不斷增加，預計對同視光眼的需求也會增加。 例如，在美國，根據防盲研究所 (RPB) 的 2021 年更新，37 個領先的科學機構正在提供主要的眼科研究經費和視覺科學家從事多種疾病導向研究的工作。我支持. 此外，北美技術先進的基礎設施有望刺激先進的自動化概要設備的生產。
由於上述原因，預計北美的同視詞市場在預測期內將顯著增長。
同義詞市場競爭對手分析
由於多個區域和全球參與者的存在，同視鏡市場在很大程度上是分散的。 這些參與者專注於增長戰略，例如新產品發布、現有產品創新和併購。 全球市場的主要市場參與者有 HAGG-STREIT GROUP、APPASAMY ASSOCIATES、Prkamya Visions、南京紅太陽光學、Rumax International、Gem Opticals Instruments Instruments 等。 這些參與者還建立戰略聯盟，例如收購和合作夥伴關係，以確保其在全球市場中的地位。
其他好處
- Excel 格式的市場預測 (ME) 表
- 三個月的分析師支持
內容
第一章介紹
- 研究假設和市場定義
- 調查範圍
第二章研究方法論
第 3 章執行摘要
第四章市場動態
- 市場概覽
- 市場驅動力
- 視力障礙的發生率增加
- 提高對視力障礙早期診斷的認識
- 對非侵入性手術的需求不斷增長
- 市場製約因素
- 同視設備成本高
- 獲得替代療法
- 波特的五力分析
- 新進入者的威脅
- 買方/消費者議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第 5 章市場細分（市場規模：百萬美元）
- 通過申請
- 診斷
- 治療
- 按設備類型
- 手冊
- 自動
- 最終用戶
- 醫院
- 診所
- 其他最終用戶
- 按地區
- 北美
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 意大利
- 西班牙
- 其他歐洲地區
- 亞太地區
- 中國
- 日本
- 印度
- 澳大利亞
- 韓國
- 其他亞太地區
- 世界其他地方
- 北美
第六章競爭格局
- 公司簡介
- HAAG-STREIT GROUP
- APPASAMY ASSOCIATES
- Prkamya Visions
- Nanjing Redsun Optical Co., Ltd
- Gem Optical Instruments Industries
- Dahlgren India
- Rumax International
- 66 Vision Tech Co., Ltd
第7章 市場機會今後動向
The synoptophore market is projected to register a CAGR of around 4% during the forecast period.
The COVID-19 pandemic caused healthcare services to reduce eye care activities, as examination procedures in ophthalmology involve close interactions with the patients, which increases the risk of infection. The American Academy of Ophthalmology (AAO recommended ophthalmologists halt non-emergency care. According to a 2021 membership survey of 416 members conducted by the AAPOS, devastating and potential impacts were observed on pediatric ophthalmology practices during the COVID-19 pandemic. Children could not get proper treatment at the right time due to restrictions on non-essential visits to eye clinics, which hampered the overall market.
The growth of the studied market can be largely attributed to the increasing incidences of visual acuity disorders, growing awareness about the early diagnosis of visual acuity disorders, and the rising demand for non-invasive processes.
Increasing incidences of visual acuity disorders contribute to the rising demand for synoptophore. Risk factors, such as stroke and traumatic head injury, associated with visual acuity disorders also increased over time. Synoptophore devices are considered reliable for the correction of such disorders. As per the 2021 statistics by the National Eye Institute (NEI), around 5% to 16% of people suffer from convergence insufficiency (CI) disorder. The young and adult population is more prone to visual acuity disorders, which augments the growth of the market studied.
Growing awareness about the early diagnosis of acuity disorders is anticipated to fuel market growth. Several orthoptic associations encourage the early diagnosis of acuity disorders, which fuels the demand for synoptophore devices. As per a 2021 article by the International Orthoptic Association (IOA), the Brazilian Orthoptic Association determines the first Monday in June as the "World Orthoptic Day." According to the International Agency for the Prevention of Blindness (IAPB), World Sight Day (WSD) is an annual day of awareness held to focus global attention on blindness and vision impairment. Such initiatives increase the early diagnosis of visual acuity disorders, thereby propelling the demand for synoptophore.
However, the high cost of synoptophore devices and access to alternatives for treating visual acuity disorders are some factors impeding the market growth.
Synoptophore Market Trends
Therapeutic Application is Expected to Witness a Significant Growth Over the Forecast Period
By application, the therapeutic segment is expected to witness significant growth over the forecast period. Synoptophore device is majorly used in the treatment of ocular motility disorders. It performs the most comprehensive binocular vision assessment and is reliable. Standard measurements allow assessment of fusional amplitudes, simultaneous perception, and stereopsis in case of abnormal retinal correspondence or horizontal, vertical, or torsional ocular misalignment.
A 2021 IEEE Conference revealed that synoptophore is increasingly used for binocular vision (BV). Synoptophore evaluates three grades of BV. As per the 2020 statistics by the American Academy of Ophthalmology (AAO), the prevalence of anisometropic amblyopia is about 5.2% in children. As per the same source, amblyopia is the most common cause of low visual acuity in children and adults in developed countries, with an incidence of 3% to 6%. The success rate via occlusion therapy is not very promising, and vision is improved to a high degree using a synoptophore to stimulate the amblyopic eye. Therefore, the demand for synoptophore devices helps healthcare facilities treat visual acuity disorders.
Thus, given the above-mentioned factors, the segment is expected to grow significantly over the forecast period.
North America is Dominant Region in the Synoptophore Market
In North America, the market in the United States is anticipated to witness significant growth over the forecast period. Major factors contributing to the growth of the market in the country are the increasing incidence of visual acuity disorders, such as strabismus and amblyopia, and the rising inclination for non-surgical treatment procedures.
As per the 2021 statistics by Prevent Blindness, in the United States, more females than males experience permanent vision loss in the ratio of 3 females for every 2 males. This fuels the adoption of vision correction using synoptophore. Moreover, increasing research and development in the region is anticipated to fuel the demand for synoptophore devices. For instance, in the United States, as per a 2021 update by the Research to Prevent Blindness (RPB), it provides major eye research funding to 37 leading scientific institutions and supports the work of vision scientists engaged in a diverse range of disease-oriented research. Furthermore, the technologically advanced infrastructure of North America is anticipated to fuel the production of advanced automatic synoptophore devices.
Thus, given the above-mentioned factors, the synoptophore market is anticipated to grow significantly over the forecast period in North America.
Synoptophore Market Competitor Analysis
The synoptophore market is nearly fragmented due to the presence of several regional and global market players. These players focus on growth strategies, such as new product launches, innovations in existing products, and mergers and acquisitions. Key market players in the global market are HAGG-STREIT GROUP, APPASAMY ASSOCIATES, Prkamya Visions, Nanjing Redsun Optical Co., Ltd, Rumax International, and Gem Opticals Instruments Industries. These players are also involved in strategic alliances, such as acquisitions and collaborations, to secure their position in the global market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Increasing Incidences of Visual Acuity Disorders
- 4.2.2 Growing Awareness on the Early Diagnosis of Visual Acuity Disorder
- 4.2.3 Rising Demand for Non-invasive Procedures
- 4.3 Market Restraints
- 4.3.1 High Cost of Synoptophore Device
- 4.3.2 Access to Alternative Treatments
- 4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size - Value in USD million)
- 5.1 By Application
- 5.1.1 Diagnostic
- 5.1.2 Therapeutic
- 5.2 By Instrument Type
- 5.2.1 Manual
- 5.2.2 Automatic
- 5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Clinics
- 5.3.3 Other End Users
- 5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Rest of the World
- 5.4.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 HAAG-STREIT GROUP
- 6.1.2 APPASAMY ASSOCIATES
- 6.1.3 Prkamya Visions
- 6.1.4 Nanjing Redsun Optical Co., Ltd
- 6.1.5 Gem Optical Instruments Industries
- 6.1.6 Dahlgren India
- 6.1.7 Rumax International
- 6.1.8 66 Vision Tech Co., Ltd
